Pharmaceutical Executive

Pharmaceutical Executive: March 2026
Volume: 46
Issue: 2

Pharmaceutical Executive: February 2026
Volume: 46
Issue: 1

Pharmaceutical Executive: December 2025
Volume: 45
Issue: 9

Pharmaceutical Executive: October 2025
Volume: 45
Issue: 8

Pharmaceutical Executive: September 2025
Volume: 45
Issue: 7

Pharmaceutical Executive: August 2025
Volume: 45
Issue: 6

Pharmaceutical Executive: June 2025
Volume: 45
Issue: 5

Pharmaceutical Executive: May 2025
Volume: 45
Issue: 4

Pharmaceutical Executive: April 2025
Volume: 45
Issue: 3

Pharmaceutical Executive: March 2025
Volume: 45
Issue: 2

Pharmaceutical Executive: February 2025
Volume: 45
Issue: 1

Pharmaceutical Executive: December 2024
Volume: 44
Issue: 12

Pharmaceutical Executive: November 2024
Volume: 44
Issue: 11

Pharmaceutical Executive: October 2024
Volume: 44
Issue: 10

Pharmaceutical Executive: September 2024
Volume: 44
Issue: 9

Pharmaceutical Executive: July/August 2024
Volume: 44
Issue: 7/8

Pharmaceutical Executive: June 2024
Volume: 44
Issue: 6

Pharmaceutical Executive: May 2024
Volume: 44
Issue: 5

Pharmaceutical Executive: April 2024
Volume: 44
Issue: 4

Pharmaceutical Executive: March 2024
Volume: 44
Issue: 3

Pharmaceutical Executive: February 2024
Volume: 44
Issue: 1

Pharmaceutical Executive: December 2023
Volume: 43
Issue: 12

Pharmaceutical Executive: November 2023
Volume: 43
Issue: 11

Pharmaceutical Executive: October 2023
Volume: 43
Issue: 10

Pharmaceutical Executive: September 2023
Volume: 43
Issue: 9

Pharmaceutical Executive: August 2023
Volume: 43
Issue: 8

Pharmaceutical Executive: July 2023
Volume: 43
Issue: 7

Pharmaceutical Executive: June 2023
Volume: 43
Issue: 6

Pharmaceutical Executive: May 2023
Volume: 43
Issue: 5

Pharmaceutical Executive: April 2023
Volume: 43
Issue: 4
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer and BioNTech Pause Covid Vaccine Study Following Low Enrollment Totals
2
The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation
3
FDA Approves Foundayo Under National Priority Voucher Program
4
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
5
